» 全て » 株価予想 » Summit Therapeutics Inc. Common Stock 予報

Summit Therapeutics Inc. Common Stock 予報: 明日, 週, 月, 5年

更新されました: April 22 · 2026 at 07:03 UTC
▲ +5.02%Market Cap $20.47B · Technical analysis Bullish · Focus area Price + volatility

予測の概要

時間枠予想価格過去歴史的洞察力
明日$26.80 +1.59%昨日$26.20 -0.67%Tomorrow's Summit Therapeutics Inc. Common Stock (SMMT) setup is anchored to $26.38 and targets $26.80 (+1.59%). The near-term read is upside; watch $27.17 / $25.59 because daily realized volatility is about 8.00%.
Tomorrow's Summit Therapeutics Inc. Common Stock (SMMT) setup is anchored to $26.38 and targets $26.80 (+1.59%). The near-term read is upside; watch $27.17 / $25.59 because daily realized volatility is about 8.00%.
$27.69 +4.95%先週$25.83 -2.08%The 7-day Summit Therapeutics Inc. Common Stock model moves from $25.83 to $27.69 (+4.95%). It gives upside momentum context for this stock, so breaks around $27.17 / $25.59 matter more than a single tick.
The 7-day Summit Therapeutics Inc. Common Stock model moves from $25.83 to $27.69 (+4.95%). It gives upside momentum context for this stock, so breaks around $27.17 / $25.59 matter more than a single tick.
$29.16 +10.54%先月$25.21 -4.43%The 1-month Summit Therapeutics Inc. Common Stock target is $29.16 (+10.54%), compared with the live reference near $26.38. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Summit Therapeutics Inc. Common Stock target is $29.16 (+10.54%), compared with the live reference near $26.38. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
$31.37 +18.93%去年$24.28 -7.95%The 1-year Summit Therapeutics Inc. Common Stock scenario points to $31.37 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Summit Therapeutics Inc. Common Stock scenario points to $31.37 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5年$36.56 +38.57%5年前$22.11 -16.20%The 5-year Summit Therapeutics Inc. Common Stock view is $36.56 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Summit Therapeutics Inc. Common Stock view is $36.56 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
明日$26.80 +1.59%
昨日$26.20 -0.67%
Tomorrow's Summit Therapeutics Inc. Common Stock (SMMT) setup is anchored to $26.38 and targets $26.80 (+1.59%). The near-term read is upside; watch $27.17 / $25.59 because daily realized volatility is about 8.00%.
$27.69 +4.95%
先週$25.83 -2.08%
The 7-day Summit Therapeutics Inc. Common Stock model moves from $25.83 to $27.69 (+4.95%). It gives upside momentum context for this stock, so breaks around $27.17 / $25.59 matter more than a single tick.
$29.16 +10.54%
先月$25.21 -4.43%
The 1-month Summit Therapeutics Inc. Common Stock target is $29.16 (+10.54%), compared with the live reference near $26.38. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
$31.37 +18.93%
去年$24.28 -7.95%
The 1-year Summit Therapeutics Inc. Common Stock scenario points to $31.37 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5年$36.56 +38.57%
5年前$22.11 -16.20%
The 5-year Summit Therapeutics Inc. Common Stock view is $36.56 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

価格表

歴史的予報強気弱気
$28.25$27.48$26.71$25.94$25.171W AgoNow7D F

テクニカル分析

売る中性買う
Bullish
2
強気
3
中性
0
弱気

主要な指標

インジケータ価値信号
Price$26.38 Mid
Daily Change+5.02% Above
Volatility Cap20.0% Mid
Confidence68% Above
Data Sourcenasdaq-screener Mid

過去のデータ

Current$26.38
Daily Change+5.02%
Market Cap$20.47B
Sourcenasdaq-screener
Current$26.38Daily Change+5.02%
Market Cap$20.47BSourcenasdaq-screener

サポートとレジスタンスのレベル

$25.59Support 1
$26.38現在
$27.17Resistance 1
shield
Support and resistance are estimated from the trusted current price until deeper historical data is available.

価格マイルストーン

主要なレベルと歴史的背景
Current$26.38Live reference price
Used as the anchor for generated forecast calculations.
Next Month$29.16Model projection+10.54%
Directional scenario based on capped drift.

予測精度

私たちのモデルのパフォーマンス
68%
指向性
Generated market-data forecast
This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.
📊
当社のアルゴリズムは、最新の価格動向、ボラティリティ体制、指標シグナルを使用して毎週再調整されます。精度は時間枠によって異なります。短期的な勢いは長期的な予測よりも信頼性が高くなります。
Short term
68%
Direction confidence
Long term
Lower
Forecast uncertainty rises with horizon

投資シナリオ

今日 $1,000 を SMMT に投資した場合
Bullish Scenario
$27.70
+5.00% from current
目標価格$27.70
シナリオUpside momentum
確率60%
Base Scenario
$29.16
+10.54%
目標価格$29.16
シナリオCapped drift
確率68%
Bearish Scenario
$25.06
-5.00% from current
目標価格$25.06
シナリオVolatility drawdown
確率32%
基礎: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

予測要因

Market Structure
Price structure reflects the latest momentum regime and support/resistance interaction.
Momentum Bullish · 72/100
24H drift+1.59%
7D drift+4.95%
30D drift+10.54%
Technical Signals
Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.
Mixed — Watching · 50/100
RSIn/a
MACDn/a
MA stackn/a
Macro Context
Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.
Risk-On Tentative · 69/100
1M outlook+10.54%
1Y outlook+18.93%
5Y outlook+38.57%

よくある質問

Q What is the Summit Therapeutics Inc. Common Stock (SMMT) forecast for tomorrow?
Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Summit Therapeutics Inc. Common Stock is projected near $26.80 versus the current reference around $26.38. That implies a modeled move of +1.59% over the next day, with realized prices still sensitive to intraday volatility.
Q What does the 7-day stock outlook suggest for SMMT?
The weekly Summit Therapeutics Inc. Common Stock model points to $27.69, which maps to an expected drift of +4.95% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.
Q How should I read the Summit Therapeutics Inc. Common Stock 1-month and 1-year targets?
The Summit Therapeutics Inc. Common Stock 1-month target is $29.16 (+10.54%), while the 1-year target is $31.37 (+18.93%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.
Q Why does the Summit Therapeutics Inc. Common Stock 5-year scenario differ from short-term rows?
The Summit Therapeutics Inc. Common Stock long-horizon scenario sits near $36.56 with a modeled change of +38.57%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.
Q Where are SMMT support and resistance zones right now?
For Summit Therapeutics Inc. Common Stock, nearest resistance is around $25.59, while nearest support is around $27.17. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.
Q How fresh is the Summit Therapeutics Inc. Common Stock market snapshot?
The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.